At the news
? NEUTRALIMPACT 1/10 144 filed Nov 4, 2026 at 16:45 ET
Jason Pitofsky, an officer of Regeneron Pharmaceuticals, filed a Form 144 notice of intent to sell 180 shares of common stock, with an approximate market value of $175,205 based on the filing price. The shares were inherited and are being sold by Stephanie Pitofsky. This is a very small sale relative to the company's $99.4B market cap and the officer's likely holdings, making it a routine administrative filing.
- Jason Pitofsky, an officer of Regeneron, filed Form 144 to sell 180 shares of common stock.
- The estimated value of the proposed sale is $175,204.80 based on the filing price.
- Shares were acquired on 08/13/2024 via inheritance from Freddy Runne.
- The sale is to be executed by Stephanie Pitofsky through J.P. Morgan Securities LLC.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access